Veeda Oncology acquires US-based ION

Ahmedabad, Jul 8 (UNI) Veeda Oncology, a global oncology clinical research organisation, has acquired US-based International Oncology Network (ION) Clinical Research, with aim to strengthen its global position in oncology.

Veeda Oncology and ION have also agreed to a five-year exclusive agreement, under which Veeda Oncology will provide clinical research support to the ION Network of sites. The acquisition of ION Clinical Research would provide Veeda with immediate access to the 50 ION sites that conduct oncology clinical research in the US, a release issued here today said.

Commenting on the acquisition, Binoy Gardi, Co-Group Managing Director and Co-Founder, Veeda Group said, ''The agreement with ION substantially increases our ability to provide our sponsors with rapid global accrual of oncology patients beyond our relationships with institutions in India, Eastern Europe, Western Europe as well as our current site relationships in the US.'' Matt Bowman, President and CEO of Veeda Oncology said that the access to the 50 ION Clinical Research sites significantly compliments our strategy of rapid access to oncology patients for global clinical trials. In addition, all the personnel of ION Clinical Research will be joining Veeda Oncology, Mr Bowman said.

UNI PVN SR SM1630